Literature DB >> 8707755

Sensitivity of L-2 type beta-lactamases from Stenotrophomonas maltophilia to serine active site beta-lactamase inhibitors.

S L Pradhananga, P J Rowling, I N Simpson, D J Payne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8707755     DOI： 10.1093/jac/37.2.394

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia.

Authors:  M B Avison; C S Higgins; C J von Heldreich; P M Bennett; T R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Induction potential of clavulanic acid toward L1 and L2 beta-lactamases of Stenotrophomonas maltophilia.

Authors:  C-W Lin; R-M Hu; S-C Huang; Y-J Hsiao; T-C Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-01       Impact factor: 3.267

3.  Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia.

Authors:  T R Walsh; A P MacGowan; P M Bennett
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 4.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Double-disk synergy test positivity in Stenotrophomonas maltophilia clinical strains.

Authors:  P Hejnar; M Kolár; Z Chmela
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.